Skip to main content
. Author manuscript; available in PMC: 2022 Jun 30.
Published in final edited form as: Mol Pharm. 2019 Feb 26;16(4):1766–1774. doi: 10.1021/acs.molpharmaceut.9b00144

Figure 5.

Figure 5.

Representative images of synthesized pCD-β-MP and dextran microparticles following 1 and 30 days incubation in physiological release buffer at 37°C (A). Particle diameters were calculated with ImageJ and presented as mean with standard deviation (B). n≥150 particles were measured per group; day 1 vs. day 30 by one-way ANOVA and Bonferroni test post-hoc were not significant as expected for pCD-β-MP (p=0.866) or Dex-MP (p=0.714).